AngioDynamics to Participate in the 27th Annual J.P. Morgan Healthcare ConferenceQUEENSBURY, N.Y.--(BUSINESS WIRE)--
Jan. 9, 2009--
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of
innovative medical devices used by interventional radiologists,
nephrologists and surgeons for the minimally invasive treatment of
cancer and peripheral vascular disease, announced today that it will
present at the 27
th Annual J.P. Morgan Healthcare Conference
in
San Francisco on
Thursday, January 15, 2009 at
10:30 a.m. PT. Eamonn
P. Hobbs, president and CEO, and Joseph Gersuk, executive vice president
and CFO, of
AngioDynamics will review the Company's business strategy
and historical financial results.
Attendance at the conference is by invitation only. Individuals can
listen to the live and archived presentation on the Internet by visiting
the investor relations portion of the Company's website at: www.angiodynamics.com.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons, and other physicians for
the minimally invasive treatment of cancer and peripheral vascular
disease. The Company's diverse product line includes market-leading
radiofrequency ablation and irreversible electroporation resection
systems, vascular access products, angiographic products and
accessories, dialysis products, angioplasty products, drainage products,
thrombolytic products, embolization products and venous products. More
information is available at www.angiodynamics.com.
CONTACT: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc. for AngioDynamics, Inc.
Investor Relations:
Doug Sherk or Jenifer Kirtland, 415-896-6820
jkirtland@evcgroup.com
Media Contact:
Chris Gale, 646-201-5431
cgale@evcgroup.com
Source: AngioDynamics, Inc.
